Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

Clinical trial NCT00034281 · COMPLETED

Trial details

NCT number: NCT00034281
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasm Pancreatic Neoplasm Lung Neoplasm Ovarian Neoplasm Renal Neoplasm

Start date: 2002-06-01
Primary completion: 2003-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.